FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

18643311000001102: OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Apr 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
63920501000001110 OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
63920601000001114 OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Is a Oxycodone hydrochloride 60mg m/r tablet false Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Has active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Has excipient Stearyl alcohol false Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Has excipient Sorbic acid false Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Is a OxyContin true Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Is a Oxycodone 60mg modified-release tablets false Inferred relationship Existential restriction modifier
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Is a Oxycodone 60mg modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets Has AMP True OxyContin 60mg modified-release tablets (Napp Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start